These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 2928806
1. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia. Lambertenghi-Deliliers G, Annaloro C, Cortelezzi A, Cortellaro M, Della Volpe A, Maiolo AT, Mozzana R, Pogliani E, Pozzoli E, Polli EE. Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806 [No Abstract] [Full Text] [Related]
2. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia. Wiernik PH, Case DC, Periman PO, Arlin ZA, Weitberg AB, Ritch PS, Todd MB. Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807 [No Abstract] [Full Text] [Related]
3. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Berman E, Raymond V, Gee T, Kempin SJ, Gulati S, Andreeff M, Kolitz J, Gabrilove J, Heller G, Young CW. Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808 [No Abstract] [Full Text] [Related]
5. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience. Candoni A, Simeone E, Tiribelli M, Malagola M, Russo D, Fanin R. Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308 [No Abstract] [Full Text] [Related]
6. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA. Petti MC, Mandelli F. Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805 [No Abstract] [Full Text] [Related]
9. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome. Estey EH, Kantarjian H, Keating M. Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966 [Abstract] [Full Text] [Related]
10. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL). Carella AM, Pungolino E, Piatti G, Giordano D, Cerri R, Risso M, Nati S. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562 [No Abstract] [Full Text] [Related]
11. Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes. Giles FJ, Kantarjian HM, Cortes JE, Faderl S, Verstovsek S, Thomas D, Garcia-Manero G, Wierda W, Ferrajoli A, Kornblau S, Mattiuzzi GN, Tsimberidou AM, Albitar M, O'Brien SM, Estey E. Leuk Res; 2005 Jun; 29(6):649-52. PubMed ID: 15863204 [Abstract] [Full Text] [Related]
12. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia. Masaoka T, Ogawa M, Yamada K, Kimura K, Ohashi Y. Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311 [Abstract] [Full Text] [Related]
13. [Early phase II study of Idarubicin combined with cytarabine in acute myelogenous leukemia. Idarubicin Study Group]. Ogawa M, Masaoka T, Yamada K, Kimura K. Gan To Kagaku Ryoho; 1993 May; 20(7):907-14. PubMed ID: 8489297 [Abstract] [Full Text] [Related]
14. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia. Saşmaz I, Tanyeli A, Bayram I, Antmen B, Yilmaz L, Küçükosmanoğlu O, Kilinç Y. Turk J Pediatr; 2004 May; 46(1):32-7. PubMed ID: 15074372 [Abstract] [Full Text] [Related]
15. [The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar]. Volkova MA, Kaletin GI. Ter Arkh; 1992 May; 64(7):18-21. PubMed ID: 1440359 [No Abstract] [Full Text] [Related]
16. Treatment of relapsed and refractory acute myeloid leukemia in adults. Lazzarino M, Morra E, Alessandrino EP, Merante S, Bernasconi P, Bonfichi M, Caldera D, Bernasconi C. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():121-3. PubMed ID: 2653487 [No Abstract] [Full Text] [Related]
17. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia. Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R. Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970 [Abstract] [Full Text] [Related]
18. Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. Russo D, Malagola M, de Vivo A, Fiacchini M, Martinelli G, Piccaluga PP, Damiani D, Candoni A, Michielutti A, Castelli M, Testoni N, Ottaviani E, Rondoni M, Pricolo G, Mazza P, Zuffa E, Zaccaria A, Raspadori D, Bocchia M, Lauria F, Bonini A, Avanzini P, Gugliotta L, Visani G, Fanin R, Baccarani M. Br J Haematol; 2005 Oct; 131(2):172-9. PubMed ID: 16197446 [Abstract] [Full Text] [Related]
19. Relapse and death during first remission in acute myeloid leukemia. Yanada M, Garcia-Manero G, Borthakur G, Ravandi F, Kantarjian H, Estey E. Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012 [No Abstract] [Full Text] [Related]
20. Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients. Pagano L, Sica S, Marra R, Voso MT, Storti S, Di Mario A, Leone G. Haematologica; 1991 Apr; 76(6):517-8. PubMed ID: 1820991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]